background
hemophagocyt
syndrom
hp
clinic
defin
combin
fever
liver
dysfunct
coagul
abnorm
pancytopenia
progress
macrophag
prolifer
throughout
reticuloendotheli
system
cytokin
overproduct
may
primari
secondari
infecti
autoimmun
tumor
diseas
consist
associ
viral
infect
still
debat
whether
microorgan
involv
pathogenesi
critic
apprais
literatur
concern
hp
relationship
infect
discuss
infectiondepend
hp
wide
observ
data
concern
incid
children
better
understand
pathophysiolog
hp
may
clarifi
interact
immun
system
various
implic
potenti
infecti
agent
epsteinbarr
viru
ebv
infect
promin
associ
hp
clonal
prolifer
hyperactiv
ebvinfect
cell
howev
number
viral
bacteri
fungal
parasit
infect
report
associ
hp
case
lowrisk
hp
corticosteroid
andor
intraven
immunoglobulin
cyclosporin
may
suffici
control
biolog
process
etoposid
recommend
mean
revers
infectiondepend
lymphohistiocyt
dysregul
highrisk
case
summari
hp
potenti
complic
variou
infect
polymeras
chain
reaction
search
infecti
agent
includ
ebv
cytomegaloviru
leishmania
recommend
clinic
set
characteris
nonremit
fever
organomegali
cytopenia
hyperferritinemia
hemophagocyt
syndrom
hp
potenti
fatal
condit
due
dysregul
lymphocyt
activ
prolifer
mainli
characteris
impair
inact
natur
killer
nk
cell
cytotox
cell
lead
macrophag
hyperactiv
overexpress
cytokin
result
process
uncontrol
ineffect
immun
activ
multiorgan
dysfunct
hemophagocytosi
throughout
reticuloendotheli
system
pathognomon
characterist
hp
activ
welldifferenti
macrophag
phagocyt
erythrocyt
leukocyt
platelet
bone
marrow
lymph
node
spleen
liver
organ
infiltr
almost
anybodi
district
may
account
mani
system
featur
hsp
still
often
underdiagnos
suboptim
manag
children
epidemiolog
data
fragmentari
syndrom
first
describ
poorlycontrol
histiocyt
prolifer
sinc
also
call
hemophagocyt
histiocytosi
macrophag
activ
syndrom
divid
primari
genet
form
secondari
reactiv
form
tabl
distinct
histor
use
differenti
case
often
fatal
infantil
hp
caus
etiolog
appear
later
life
better
prognosi
differ
may
artifici
scholast
primari
form
occur
age
infanc
earli
childhood
primari
secondari
form
precipit
infect
substanti
risk
mortal
even
secondari
hp
occur
imbal
insuffici
host
defens
obstin
hyperinflamm
heterogen
trigger
event
infecti
rheumat
neoplast
natur
therefor
clinic
diseas
result
signatur
dysregul
immun
activ
lead
macrophag
prolifer
widespread
hemophagocytosi
reticuloendotheli
system
aim
review
make
critic
apprais
literatur
concern
infectionrel
hp
paediatr
genet
hp
heterogen
aris
defect
critic
regulatori
pathway
respons
natur
termin
immun
respons
lead
failur
homeostat
remov
cell
superflu
danger
host
sinc
variou
genet
loci
relat
activ
perforin
granzym
granul
associ
genet
autosom
recess
hp
thu
explain
impair
absent
function
nk
cell
cytotox
cell
famili
form
first
describ
autosom
recess
disord
estim
occur
birth
usual
appear
first
year
life
sporad
case
hp
associ
multipl
genet
mutat
also
describ
differ
primari
form
hp
associ
immun
defici
includ
chediakhigashi
syndrom
griscelli
syndrom
xlink
lymphoprolif
syndrom
wiskottaldrich
syndrom
sever
combin
immunodefici
lysinur
protein
intoler
hermanskypudlak
syndrom
acquir
hp
also
associ
varieti
viral
bacteri
mycobacteri
fungal
parasit
infect
autoimmun
diseas
autoinflammatori
syndrom
tumour
particularli
cell
malign
constel
sign
symptom
hp
specif
none
biochem
abnorm
distinct
dramat
present
syndrom
includ
unremit
fever
visceromegali
thrombocytopenia
lethargi
seizur
skin
rash
pulmonari
failur
cardiac
andor
renal
involv
mortal
rate
common
laboratori
find
due
liver
dysfunct
includ
low
fibrinogen
high
serum
triglycerid
ferritin
level
two
highli
diagnost
clue
increas
plasma
concentr
alpha
chain
receptor
also
known
impair
nk
cell
activ
treatment
lifesav
clinic
criteria
occur
late
cours
diseas
necessari
satisfi
criteria
begin
therapi
hallmark
hp
phagocytosi
blood
cell
precursor
bone
marrow
aspir
typic
reveal
normal
matur
cell
lineag
infiltr
activ
macrophag
stuf
blood
cell
criteria
diagnosi
hp
basi
clinic
laboratori
histopatolog
find
follow
genet
diagnosi
gene
known
caus
syndrom
sign
symptom
least
five
follow
criteria
fever
b
splenomegali
c
cytopenia
minimum
cell
line
reduc
hypertriglyceridemia
mgdl
andor
hypofibrinogenemia
gdl
e
hemophagocytosi
involv
organ
f
littl
nk
cell
activ
g
increas
ferritin
mgl
h
increas
solubl
serum
receptor
alpha
uml
main
pathophysiolog
abnorm
hp
cytokin
dysfunct
lead
uncontrol
accumul
ectop
migrat
activ
lymphocyt
antigenpres
cell
histiocyt
multisystem
inflamm
pathophysiolog
acquir
hp
fulli
defin
defici
cytolyt
activ
lead
persist
activ
lymphocyt
histiocyt
follow
hypersecret
proinflamatori
cytokin
high
solubl
receptor
level
correl
prognosi
associ
hp
infect
wide
document
famili
sporad
case
often
precipit
acut
infect
must
also
point
everi
form
hp
mimic
infecti
diseas
overwhelm
bacteri
sepsi
thu
hinder
diagnosi
precipit
treatabl
infecti
ill
virusassoci
hp
first
describ
risdal
et
al
whose
seri
consist
patient
immunocompromis
without
confirm
genet
acquir
immunodefici
show
serolog
sign
viral
infect
sinc
report
hp
associ
host
infect
epsteinbarr
viru
ebv
commonli
report
trigger
hp
epidemiolog
ebvrel
hp
well
known
although
higher
incid
observ
asian
countri
theoris
may
pathogen
viral
strain
genet
similar
strain
observ
nasopharyng
carcinoma
cell
line
two
form
ebvrel
hp
describ
first
occur
primari
infect
second
reactiv
process
primari
infect
ebv
typic
infect
replic
b
cell
wherea
ebvspecif
cytotox
cell
requir
produc
memori
cell
rare
case
ebv
may
infect
nk
cell
induc
persist
ebv
infect
may
lead
chronic
activ
ebv
infect
lymphoprolif
disord
fulmin
ebvrel
hp
serolog
test
help
determin
whether
ebvassoci
hp
occur
set
acut
infect
result
reactiv
process
addit
realtim
polymeras
chain
reaction
pcr
detect
quantif
ebv
nucleic
acid
import
laboratori
mean
adequ
reflect
viral
replic
assess
ebv
load
patient
ebvrel
hp
quantit
analysi
cellfre
ebv
genom
copi
number
four
month
treatment
assess
therapeut
respons
prognost
signific
clonal
expans
ebvinfect
lymphocyt
demonstr
ebvrel
hp
ebvposit
cell
lymphoma
basi
presenc
homogen
viral
termin
repeat
sequenc
clonal
infect
lymphocyt
suggest
find
monoclon
rearrang
cell
receptoralpha
gene
ebvrel
hp
distinct
monoclon
prolifer
lymphocyt
seen
ebvrel
hp
ebvposit
cell
lymphoma
may
describ
extrem
spectrum
disord
lymphocyt
prolifer
follow
ebv
infect
inflammatori
cytokin
overproduct
seen
patient
ebvrel
hp
tend
much
pronounc
observ
patient
form
hp
infect
associ
hp
ebv
infect
worst
prognosi
presenc
underli
hereditari
disord
diffus
intravascular
coagul
neutropenia
central
nervou
system
involv
treatment
strategi
vari
significantli
depend
clinic
featur
infect
mild
case
ebvrel
hp
treat
conserv
spontan
regress
report
antivir
therapi
acyclovir
ganciclovir
cidofovir
led
disappoint
result
case
sever
ebvrel
hp
introduct
immunochemotherapi
necessari
allogen
stem
cell
transplant
radic
chang
histori
prognosi
diseas
case
optim
treatment
strategi
centr
immunosuppress
medic
inhibit
overact
nk
cell
respons
ie
corticosteroid
cyclosporin
intraven
immunoglobulin
antithymocyt
globulin
etoposid
rituximab
plasma
blood
exchang
transfus
hematopoiet
stem
cell
transplant
last
treatment
resort
refractori
form
ebvrel
hp
case
ebv
infect
occur
genet
form
hp
frequent
herp
virus
associ
hp
ebv
cytomegaloviru
cmv
human
herp
viru
cmv
upregul
tumour
necrosi
factor
gene
express
associ
hp
otherwis
healthi
patient
patient
inflammatori
bowel
diseas
rheumatolog
diseas
cancer
transplant
recipi
hp
observ
seven
seri
patient
undergo
hematopoiet
stem
cell
transplant
trigger
cmv
three
case
younger
age
may
associ
wors
prognosi
recent
studi
shown
use
specif
anticmv
therapi
cmv
immunoglobulin
foscarnet
ganciclovir
may
therapeut
associ
hp
patient
case
occur
patient
lymphoprolif
disord
immunocompromis
patient
rare
immunocompet
host
treatment
base
etoposid
ganciclovir
foscarnet
rituximab
led
success
result
hp
associ
human
immunodefici
viru
hiv
infect
alon
wide
varieti
underli
disord
like
condit
underestim
hiv
infect
hp
mani
clinic
laboratori
similar
bone
marrow
biopsi
taken
hiv
patient
start
highli
activ
antiretrovir
therapi
show
activ
sign
hemophagocytosi
hivrel
hp
observ
case
acut
late
hiv
infect
conjunct
immun
reconstitut
inflammatori
syndrom
opportunist
infect
malign
hp
may
even
initi
present
hiv
infect
suggest
hiv
may
play
direct
role
trigger
syndrom
common
viral
trigger
hp
hiv
patient
ebv
cmv
ebvrel
hp
seem
frequent
hivinfect
children
influenzarel
hp
rare
report
immunocompromis
otherwis
healthi
children
one
fatal
case
hp
observ
among
children
hospitalis
season
influenza
prospect
pediatr
studi
reactiv
hp
also
associ
avian
swine
nonpandem
influenza
particular
patient
sever
avian
influenza
infect
symptom
laboratori
find
similar
observ
patient
hp
mainli
enceph
organ
dysfunct
hemophagocytosi
bone
marrow
failur
proinflammatori
cytokin
overproduct
clinic
studi
found
mutat
viral
gene
ha
na
significantli
relat
cytokin
releas
demonstr
recombin
hemagglutinin
viru
suppress
perforin
express
reduc
cytotox
cell
includ
abil
kill
cell
author
suggest
treatment
shorter
cours
etoposid
dexamethason
hp
report
case
parvoviru
infect
hereditari
spherocytosi
underli
diseas
fewer
half
children
patient
receiv
treatment
surviv
thu
suggest
prognosi
parvovirusassoci
hp
better
viralmedi
form
hp
fulmin
viral
hepat
may
mimic
even
caus
hp
hepat
viru
frequent
associ
hp
hepatotrop
virus
fifteen
case
includ
children
describ
mainli
asia
three
patient
also
concurr
rheumatolog
diseas
system
juvenil
idiopath
arthriti
still
diseas
two
also
hepat
c
treatment
consist
corticosteroid
various
combin
intraven
immunoglobulin
four
patient
receiv
specif
treatment
experienc
favour
outcom
enterovirusrel
hp
describ
pediatr
case
five
occur
infant
age
year
oldest
patient
year
old
underli
diseas
found
four
patient
experienc
fatal
outcom
lymphoid
neoplasm
lymphoblast
leukemia
juvenil
idiopath
arthriti
ten
patient
receiv
intraven
immunoglobulin
six
combin
corticosteroid
seven
patient
surviv
virus
associ
hp
includ
adenoviru
paramyxoviru
lead
measl
mump
rubella
viru
human
parainfluenza
virus
flaviviru
lead
dengu
fever
hantaviru
lead
hemorrhag
fever
sever
acut
respiratori
syndrom
treat
vari
cours
corticosteroid
intraven
immunoglobulin
reactiv
hp
frequent
associ
intracellular
pathogen
pathophysiolog
hp
associ
nonvir
agent
may
relat
product
high
level
activ
cytokin
host
lymphocyt
monocyt
although
pathophysiolog
respons
host
immun
system
infecti
agent
fulli
understood
hypothesis
function
defici
nk
cytox
cell
may
occur
ill
hp
associ
dissemin
mycobacterium
tuberculosi
infect
thirtysix
case
includ
infant
children
far
report
approxim
half
accompani
comorbid
eight
patient
endstag
renal
diseas
receiv
hemodialysi
undergon
renal
transplant
four
histori
malign
two
aid
one
sarcoidosi
fever
frequent
clinic
featur
upon
present
combin
visceromegali
pancytopenia
patient
underw
bone
marrow
aspir
confirm
hemophagocytosi
evid
extrapulmonari
tuberculosi
found
case
conclud
remark
report
state
tuberculosisrel
hp
poor
prognosi
mortal
rate
approxim
although
antitubercul
immunomodulatori
therapi
consist
highdos
corticosteroid
intraven
immunoglobulin
antithymocyt
globulin
cyclosporin
epipodophyllotoxin
plasma
exchang
may
lead
better
outcom
earli
diagnost
confirm
time
administr
antitubercul
medic
seem
crucial
patient
one
report
case
hp
occur
childhood
vaccin
bacillu
hp
also
describ
associ
brucellosi
brucella
melitensi
frequent
isol
organ
leptospirosi
caus
lifethreaten
hp
result
insuffici
misdirect
immunolog
respons
leptospira
antibiot
treatment
alon
suffici
case
treatment
corticosteroid
intraven
immunoglobulin
etoposid
requir
rickettsi
diseas
transmit
human
arthropod
bite
usual
control
intracellular
level
nitric
oxid
synthesi
hydrogen
peroxid
product
tryptophan
degrad
also
relat
hp
overal
case
rickettsi
diseas
confirm
serolog
complic
hp
publish
period
case
occur
patient
less
year
prognosi
influenc
specif
rickettsia
speci
patient
immunolog
equip
delay
antibiot
therapi
corticosteroid
therapi
sepsi
caus
multidrugresist
acinetobact
baumannii
follow
urinari
tract
infect
report
first
time
previous
healthi
child
recov
multipl
dose
granulocyt
coloni
stimul
factor
red
blood
cellplatelet
transfus
without
cytotox
treatment
immunotherapi
hp
associ
leishmania
donovani
leishmania
infantum
infect
leishmaniasi
may
also
mimic
syndrom
characterist
associ
organomegali
pancytopenia
particularli
import
nonendem
area
viscer
leishmaniasi
unlik
includ
differenti
diagnosi
repeat
bone
marrow
smear
often
requir
identifi
leishmania
speci
mean
pcr
speciesspecif
probe
specif
antileishmania
treatment
amphotericin
b
usual
suffici
control
hp
unfortun
sporad
case
undiagnos
leishmaniasi
treat
hp
fatal
consequ
malaria
caus
plasmodium
falciparum
plasmodium
vivax
toxoplasmosi
babesiosi
strongyloidiasi
rare
identifi
associ
hp
histori
travel
endem
countri
may
help
identifi
trigger
agent
yeast
candida
spp
cryptococcu
spp
pneumocysti
spp
mould
histoplasma
spp
aspergillu
spp
fusarium
spp
associ
occurr
hp
commonli
hiv
infect
neoplast
diseas
protract
corticosteroid
administr
transplant
dissemin
penicillium
marneffei
infect
common
among
hivinfect
patient
mani
region
southeast
asia
first
case
hp
associ
penicilliosi
thai
hivinfect
child
report
complet
recoveri
antifung
intraven
immunoglobulin
therapi
mani
immunolog
neoplast
genet
disord
may
underli
hp
infecti
caus
preval
frequent
report
associ
syndrom
specif
clinic
laboratori
test
microbiolog
identif
hp
follow
serum
cryptococc
antigen
serum
galactomannan
fatal
outcom
may
occur
infectionrel
hp
treat
support
multidisciplinari
approach
experienc
clinician
infecti
diseas
specialist
requir
order
ensur
appropri
manag
syndrom
precipit
underli
infect
pediatrician
alert
awar
risk
syndrom
earli
diagnosi
chang
natur
histori
shown
prompt
treatment
improv
overal
prognosi
combin
high
fever
unrespons
broadspectrum
antibiot
hyperferritinemia
hypertriglyceridemia
hypofibrinogenemia
cytopenia
organomegali
characterist
histolog
find
set
infecti
process
particularli
ebv
infect
also
viral
bacteri
parasit
fungal
infect
key
diagnost
clue
better
understand
pathophysiolog
hp
clarifi
interact
immun
system
pathway
infect
specif
antimicrobi
therapi
benefici
select
case
wherea
antivir
drug
seem
cur
sever
case
infectiondepend
hp
requir
immunosuppress
chemotherapeut
agent
bone
marrow
transplant
ultim
choic
persist
refractori
case
hemophagocyt
syndrom
hp
occur
rare
complic
variou
infect
children
clonal
prolifer
lymphocyt
excess
activ
macrophag
trigger
differ
infecti
agent
thu
indic
infect
per
se
involv
pathogenet
mechan
process
number
studi
demonstr
hp
frequent
trigger
one
mani
differ
viral
bacteri
parasit
fungal
infect
larg
differ
term
treatment
respons
overal
outcom
patient
meet
criteria
hp
undergo
initi
test
diagnos
underli
infect
organ
guid
epidemiolog
data
patient
medic
histori
polymeras
chain
reaction
search
infecti
agent
includ
ebv
cmv
leishmania
recommend
clinic
scenario
characteris
unremit
fever
organomegali
cytopenia
hyperferritinemia
hp
may
associ
mani
infecti
diseas
immunolog
neoplast
genet
disord
close
cooper
pediatrician
infecti
diseas
specialist
crucial
order
defin
precipit
underli
condit
author
declar
compet
interest
author
contribut
va
dr
draft
manuscript
contribut
equal
prepar
se
revis
draft
made
substanti
scientif
contribut
author
read
approv
final
version
manuscript
